Avalanche (AVAX) attracted institutional investment of millions during the year 2025. The token experienced difficulties during this period. Messari reports thatAvalanche (AVAX) attracted institutional investment of millions during the year 2025. The token experienced difficulties during this period. Messari reports that

Avalanche (AVAX) 60% Plunge Despite $1.3B Institutional Uprise

2026/01/30 23:00
3 min read

Avalanche (AVAX) attracted institutional investment of millions during the year 2025. The token experienced difficulties during this period. Messari reports that while adoption expanded across tokenized funds, loans, and indices, AVAX suffered one of its weakest quarters, falling nearly 60% in Q4. The network experienced growth while the tokens displayed different performance results.

AVAX received increased support from institutional investors after real-world asset tokenization started to become popular. The total value locked in tokenized RWAs on the network surged 68.6% in the fourth quarter and nearly 950% over the year, surpassing $1.3 billion. BlackRock launched its $500 million USD Institutional Digital Liquidity Fund (BUIDL) on AVAX in November, which became a major catalyst for the fund.

Fortune 500 fintech FIS created additional momentum by establishing a partnership with Avalanche-based Intain which provides loan tokenization services. The Intain platform now allows approximately 2000 U.S. banks to securitize over 6 billion dollars in loans using the AVAX blockchain. The S&P Dow Jones Index partnered with Dinari to create the S&P Digital Markets 50 Index which tracks both crypto-related stocks and tokens on the Avalanche blockchain.

Source: Messari Report

Traditional finance institutions are increasing their participation in blockchain-based financial products which indicates that they now possess greater confidence in these products. U.S. authorities have become more permissive to crypto experimentation during the past year while regulatory sentiment has become less strict.

Also Read: Avalanche (AVAX) Nears Key Support Level as Short-Term Momentum Faces Test

Avalanche Faces Token Pressure Despite Institutional Growth

The ecosystem expansion led to AVAX underperforming the general cryptocurrency market. The token started Q4 2025 at approximately $12.3 and it has experienced a 10.5% decline which brings its current value to about $11. AVAX has experienced a 92% price drop from its November 2021 peak value of $144.96 while Bitcoin and Ether reached new peak values during this market cycle.

Source: Messari Report

The market disconnect demonstrates how fundamental network strength in cryptocurrency markets fails to deliver immediate price growth.

Avalanche DeFi Activity Strengthens as Usage Rises

The decentralized finance sector of Avalanche showed substantial progress through its financial performance. The DeFi protocols experienced a total value increase of 34.5% which brought their assets to 97.5 million AVAX during the fourth quarter. The number of daily transactions increased by 63% which achieved approximately 2.1 million transactions because more users began to use on-chain activities.

Source: Messari Report

AVAX’s main chain showed stable performance through its stablecoin operations while its total market capitalization increased to $1.741 billion. Tether’s USDT emerged as the leading stablecoin in the market by surpassing USDC through its 42% market share which equals approximately $736.6 million of USD in circulation.

Avalanche creates actual practical applications which draw significant interest from institutional investors. The network continues to demonstrate a strong development path. The token needs to achieve more price recovery before reaching its previous value.

Also Read: Avalanche (AVAX) ETF Goes Live on Nasdaq, Putting $15.50 Level in Focus

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The Silver Price Doesn’t Look Real – And This Video Explains Why

The Silver Price Doesn’t Look Real – And This Video Explains Why

The Silver (XAG) price has been acting strange lately. Just when it looked like the market was settling down, a new argument started spreading fast: silver might
Share
Captainaltcoin2026/02/11 04:00
Will XRP Price Increase In September 2025?

Will XRP Price Increase In September 2025?

Ripple XRP is a cryptocurrency that primarily focuses on building a decentralised payments network to facilitate low-cost and cross-border transactions. It’s a native digital currency of the Ripple network, which works as a blockchain called the XRP Ledger (XRPL). It utilised a shared, distributed ledger to track account balances and transactions. What Do XRP Charts Reveal? […]
Share
Tronweekly2025/09/18 00:00
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11